Back
Trevi Therapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Buy
52
TRVI
Trevi Therapeutics
Last Price:
$4.27
Seasonality Move:
58.97%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing slight selling pressure.
Trevi Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.18 | Buy |
| 20-day SMA: | 3.49 | Buy |
| 50-day SMA: | 3.19 | Buy |
| 200-day SMA: | 3 | Buy |
| 8-day EMA: | 4.06 | Buy |
| 20-day EMA: | 3.69 | Buy |
| 50-day EMA: | 3.34 | Buy |
| 200-day EMA: | 2.93 | Buy |
Trevi Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 67.55 | Buy |
| Chaikin Money Flow: | -205210 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.66 - 4.06) | Buy |
| Bollinger Bands (100): | (2.7 - 3.54) | Buy |
Trevi Therapeutics Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 4.27 while TRVI 8-day simple moving average is 4.18, which is a Buy signal.
-
The stock price of TRVI is 4.27 while Trevi Therapeutics 20-day SMA is 3.49, which makes it a Buy.
-
Trevi Therapeutics 50-day simple moving average is 3.19 while TRVI share price is 4.27, making it a Buy technically.
-
TRVI stock price is 4.27 and Trevi Therapeutics 200-day simple moving average is 3.00, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
52
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a BuyThe current Trevi Therapeutics [TRVI] share price is $4.27. The Score for TRVI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
328.2M
Price in USD:
4.27
Share Volume:
757.3K
Trevi Therapeutics 52-Week Range
52-Week High:
4.68
52-Week Low:
1.27
Buy
52
Trevi Therapeutics (TRVI)
is a Buy
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?The Trevi Therapeutics stock price is 4.27 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is not overvalued.
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 4.27 while TRVI 8-day exponential moving average is 4.06, which is a Buy signal.
-
The stock price of TRVI is 4.27 while Trevi Therapeutics 20-day EMA is 3.69, which makes it a Buy.
-
Trevi Therapeutics 50-day exponential moving average is 3.34 while TRVI share price is 4.27, making it a Buy technically.
-
TRVI stock price is 4.27 and Trevi Therapeutics 200-day simple moving average is 2.93, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.00 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 0.35, suggesting Trevi Therapeutics is a Buy
-
Trevi Therapeutics Relative Strength Index (RSI) is 67.55, which suggest Trevi Therapeutics is overbought
-
The Bollinger Bands (25) for Trevi Therapeutics is (2.66 - 4.06), which suggest Trevi Therapeutics is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics is (2.7 - 3.54), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.